Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$21.21 USD
+0.26 (1.24%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $21.21 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Amphastar Pharmaceuticals, Inc. has a market cap of $987.56M, which represents its share price of $20.95 multiplied by its outstanding shares number of 47.14M. As a small-cap company, AMPH's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AMPH 21.21 +0.26(1.24%)
Will AMPH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMPH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMPH
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
Bausch Health (BHC) Lags Q2 Earnings Estimates
AMPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Amphastar (AMPH) a New Buy Stock
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
Here's Why Amphastar (AMPH) is Poised for a Turnaround After Losing 13.1% in 4 Weeks
Other News for AMPH
Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More
Amphastar Pharmaceuticals Inc (AMPH) Announces Second Quarter 2025 Earnings Release and ...
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August ...
Amphenol (AMPH) Anticipates Strong Q3 Revenue Growth Amid Electronics Boom | AMPH Stock News
Amphastar sees Q3 adjusted EPS 77c-79c, consensus 69c